CYP 0.00% 27.0¢ cynata therapeutics limited

CYP vs MSB, page-5

  1. 509 Posts.
    lightbulb Created with Sketch. 380

    "There is enough space for more than one leading company in the therapeutic stem cell space in the coming years/decades"

    Yes but msb may get exclusive rights beforehand. CYP better hurry up!
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.